Outcomes of switching from crizotinib to alectinib in patients with advanced non-small cell lung cancer with anaplastic lymphoma kinase fusion - Pan, Yingying; Xiao, Wenjing; Ye, Feng; Wang, Huijuan; Shen, Yihong; Yu, Xinmin; Han, Xiao; Chu, Qian; Zhou, Caicun; Zhang, Zhihong; Ren, Shengxiang (Annals of Translational Medicine, 2021)